Experience with trifluridin/tipiracil in treatment of patient with metastatic rectal cancer
MUDr. Michal Vočka
Onkologická klinika 1. LF UK a VFN, Praha
Trifluridine/tipiracil (Lonsurf), combination of trifluridine (analogue of thymidine-nucleoside) and tipiracil (thymidine phosphorylase inhibitor involved in thymidine catabolism), is one of the options for a higher-line treatment in metastatic colorectal cancer patients. The case report describes the use of this drug in the fourth line, when the disease was stabilized for 17 months without any significant side effects associated with the therapy.
colorectal cancer, palliative, trifluridin/tipiracil, survival, CNS
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...